Vertex Pharmaceuticals Incorporated (VRTX) stock is higher by 72.72% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives VRTX stock a score of 85 out of a possible 100.
That rank is influenced by a short-term technical score of 98. VRTX's rank also includes a long-term technical score of 93. The fundamental score for VRTX is 66. In addition to the average rating from Wall Street analysts, VRTX stock has a mean target price of 286.736. This means analysts expect the stock to decline 6.07% over the next 12 months.
What's Happening with VRTX Stock Today
Vertex Pharmaceuticals Incorporated (VRTX) stock is higher by 4.79% while the S&P 500 has fallen -0.06% as of 11:32 AM on Tuesday, Jul 7. VRTX is higher by $13.97 from the previous closing price of $291.31 on volume of 563,304 shares. Over the past year the S&P 500 has risen 6.79% while VRTX is higher by 72.72%. VRTX earned $5.76 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 52.89.
Click Here to get the full Stock Score Report on Vertex Pharmaceuticals Incorporated (VRTX) Stock.
